The Montreal Cognitive Assessment is superior to the Mini-Mental State Examination at detecting cognitive dysfunction in SLE.
Lesinurad combined with febuxostat showed superior serum urate reduction vs febuxostat alone in patients with tophaceous gout requiring additional therapy.
Use of the JAK inhibitor peficitinib in combination with certain csDMARDs results in a dose-dependent ACR20 response rate in patients with RA over 12 weeks.
MRI may assist in identifying patients with unclassified arthritis who will develop rheumatoid arthritis (RA) — primarily in patients with UA presenting with oligoarthritis.
Patients with multiple sclerosis (MS) have lower bone mineral density and greater rates of osteoporosis than healthy controls.
Approximately 1 in 3 patients with RA who discontinued tofacitinib maintained low disease activity after 1 year.
Muscle MRI may complement a physician's objective assessment in juvenile dermatomyositis, although negative MRI findings should not preclude treatment continuation.
The Dietary Approaches to Stop Hypertension (DASH) diet is effective for prevention of gout.
High serum uric acid levels are associated with a high risk of new-onset gout and gout recurrence, while lowering SUA levels can significantly reduce incident and recurrent gout.
Much concern has been voiced regarding legislation allowing the substitution of biosimilars for branded drugs.
Preclinical alterations in levels of soluble mediators may predict transition to SLE for unaffected relatives of patients with SLE.
This study included phase 3 trial in patients taking baricitinib, adalimumab, or placebo in addition to methotrexate background therapy.
A phase 3, double-blind, randomized placebo-controlled study was conducted in 551 patients with active RA who received secukinumab, abatacept, or placebo.
Consuming adequate amounts of the right nutrients can help relieve symptoms and improve outcomes in patients with systemic lupus erythematosus.
Telerheumatology can improve healthcare access, patient outcomes, and costs
The innovative triage and referral system introduced by CReATe Rheum successfully facilitated timely access to care for rheumatology patients. Further long-term follow-up demonstrated that, despite an increasing number of referrals, CReATe Rheum can accurately cope with increased demand.
"As [a member] of the NIH Task Force on pain, I would say that one of the things that's important to show is that an interdisciplinary model and a multimodal approach are effective and cost-effective, as they certainly are expensive."
Dermatologists are in a key position to screen for psoriatic arthritis (PsA), as the overlapping and variable symptoms of the disease require multidisciplinary care.
OA is traditionally thought of as a slowly progressive disorder, but 3% to 4% of individuals at risk for OA develop it in less than 4 years and some in less than 12 months. Individuals who are older, overweight, and/or have a new knee injury are more likely to develop this accelerated form of knee OA
Foot synovitis may predict patients who are at higher risk of unstable rheumatoid arthritis (RA) remission.
Variables linked to PsA development include severe psoriasis, low level of education, retinoid use.
A new study published suggests that it may be time to produce new algorithms for assessing cardiovascular disease risk in patients with rheumatoid arthritis.
For adults with Crohn's, rheumatoid arthritis, or psoriasis.
New research suggests that patients with severe obesity who undergo bariatric surgery experience improvements in pain, physical function, and walking capacity over 3 years.
Self-report measures capture the complex nature of this debilitating, chronic condition.
Focus will be on quality of care and cost cutting; hospitals on board but orthopedic surgeons are wary.
New research suggests that PNBs are linked to better medical and economic outcomes in patients receiving hip and knee replacement.
The use of a postoperative risk stratification model can serve to reduce the costs associated with hospital readmission by identifying patients with specific risk factors.
The pregnant patient with rheumatoid arthritis may need to have pain medication changed due to potential effects on the fetus.
Serotonin shows it plays a fundamental role in RA through regulation of the Th17/T-regulatory cell balance.
Clinical Pain Advisor Articles
- FDA to Remove Pain Drug from the Market
- Disc Replacement Surgery for Low Back Pain Improves Long-Term Outcomes
- Telephone-Based vs In-Person CBT for Chronic Back Pain
- Fiber, Chondroitin Regimen Leads to Knee Pain Relief in Osteoarthritis
- Persistent Pain Linked With Greater Memory Decline & Dementia Probability
- Overemphasis on Performance and Achievement Hurting Medical Students
- Sirukumab Improves Depression in Patients With Rheumatoid Arthritis
- Let us Know What You Want to Read About on Clinical Pain Advisor
- Threats Posed by Congressional Acts to National Health Initiatives
- Case Study: Fever, Low Platelets and Right-Sided Abdominal Pain